CEO Lisa Crossley gave a great interview giving a thorough summary of RHT’s developing progress and clear explanations of where the company is, what they are planning to do. An important description of the enhanced health aids that their iU complex expanded coverage. Originally the RHT program was aimed at the critically ill patient who via virtual management was capable of enhancing the survival rate of the patients and reducing the needs of hospital episodes. Now they can offer virtual care to monitor body functions that would indicate any bodily functions that could be monitored to enhance the physical function of the patient A huge increase of potential health-conscious candidates! “APPLE” in SPADES I urge any investor to access the interview.
Thus Dr.Cossley can be comfortable in predicting that very large numbers of clients will be interested in being protected by the RHT program.
MILLIONS become possible. She then discusses the role of Cognizant-CTSH in providing their existing data managers to enable rapid and accurate uploading of the clients into the system. CTSH,yesterday released their latest quarterly financial report
Q4 revenue of $4.8 billion and full-year revenue of $18.5 billion
- Digital revenue grew 20% and 19% year-over-year in Q4 and full-year, respectively
- Q4 bookings growth of 22% year-over-year; full-year bookings of $23.1 billion, 1.2x book-to-bill
- Full-year operating cash flow of $2.5 billion and free cash flow¹ of $2.2 billion
- Full-year 2022 revenue growth guidance 7.8% to 10.8%, or 8.5% to 11.5% in constant currency
- Q1 2022 quarterly dividend increased to $0.27 per share
An established major company whose workforce is trained in data managementThe agreed relationship saves RHT the huge expense of training the large number of employees needed to handle millions of clients and the costly time needed for their training. She explained that the payment RHT would receive from a patient would be equal to what they receive now and CTSH would receive payment from the same source [Medicaid and Medicare } Based on their scheduled payments per application.
This raises a v ery interesting situation that non medical persons is unaware. Doctors are basically paid for procedures as the care for the matter whether it is done correctly or not! The quality of care is a difficult management problem. One measure is the survival of the patient. Unfortunately that end result can place the physician in a questionable situation. The doctor becomes selective in the patients he treats. Lately, we notice physicians are limiting their services to under 70/75 years of age so that they are treating healthier persons. Generic specialists are now being encouraged to be trained to fill the need
It was at this time in the interview that Dr Crossley was asked if she thought RHT might become a take over candidate. She seemed not concerned. I thought the most likely candidate would be CTSH but they would have to develop the medical staff to run the program and probably the cost benefit wouldn’t be appealing.
Her guidance of 2022 realizing a 40 Million dollar goal would , to me, be very conservative because that figure ,she admitted, didn’t include any hoped- for announcement from CTSH of major MILLION additions uploading
When last year Dr. Crossly said they were hoping to list the company on the Nasdaq I predicted that by May of this year the share price would be $2.50 and management would do a reverse split which would give the 1 share [2shares reduced to 1} a value of $5.00 which meets NASDAQ’s requirements. I now say the share price will be significantly more than $5.00 by May at the latest so listing should be achieved.``````
So in conclusion The patient is greatly aided in maintaining good health. The medical providers receive significant revenue for providing care. The tax payer is happy to see fewer costs due to fewer hospital needs. The hospitals may feel the lesser demand but elements such as covid will soften their concerns.
